We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Latisse Web Page Cited in FDA Untitled Letter
Latisse Web Page Cited in FDA Untitled Letter
September 25, 2009
The FDA has warned Allergan for omitting and minimizing risks in web advertising for its prescription eyelash enhancer Latisse.